{"SPADE_UN_11080": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2012/0328692 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2012_0328692_A1", "Patent Type": "Patent Application", "Publication Date": "2012-12-27", "Family Info": "Unknown", "Patent Title": "Potent D-peptide antagonists of mdm2 and mdmx for anticancer therapy.", "Abstract": "The present invention relates to a group of MDM2 and MDMX antagonists, namely, D-peptides, variants thereof, and stapled D-peptides, along with pharmaceutical compositions comprising the antagonists, and methods of treating conditions such as cancer using the antagonists."}], "Sequence Information": {"SPADE ID": "SPADE_UN_11080", "Sequence": "TAWYANFEKLXR", "Sequence Length": 12, "Peptide Name": "Sequence 11 from Patent US 20120328692", "Source": "Synthetic construct", "Biological Activity": ["Anticancer"], "Frequent Amino Acids": "AEF", "Absent Amino Acids": "CDGHIMOPQSUV", "Basic Residues": 2, "Acidic Residues": 1, "Hydrophobic Residues": 6, "Polar Residues": 7, "Positive Residues": 2, "Negative Residues": 1, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_11084", "Similarity": 1.0, "Sequence": "TAWYANEKLR"}, {"SPADE_ID": "SPADE_UN_11931", "Similarity": 1.0, "Sequence": "GATYAKKIIKTITKIATTAW"}, {"SPADE_ID": "SPADE_UN_11081", "Similarity": 1.0, "Sequence": "WYANFEKLR"}]}}}